Post hoc analysis of the PROTECTION trial (3,481 cardiac surgery patients): amino acids reduced AKI similarly with brief (≤48 h) or prolonged infusion (interaction P=0.89); ICU mortality fell with brief (1.9% to 1.0%) but rose with prolonged (2.5% to 3.5%).
Secondary analysisn = 3,481 patients
Landoni et al. Association of duration of amino acids infusion and renal protection: a secondary analysis of the PROTECTION trial